Invesco NASDAQ Biotechnology ETF
IBBQ
13 hedge funds and large institutions have $7.03M invested in Invesco NASDAQ Biotechnology ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
4.58% more ownership
Funds ownership: 37.62% → 42.2% (+4.6%)
4% less capital invested
Capital invested by funds: $7.3M → $7.03M (-$276K)
7% less funds holding
Funds holding: 14 → 13 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$379K |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$102K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$52.2K |
| 4 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$1.08K |
| 5 |
CGL
Clarius Group LLC
Seattle,
Washington
|
+$796 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$301K |
| 2 |
CIAS
Capital Investment Advisory Services
Raleigh,
North Carolina
|
-$225K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$33K |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$17.8K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$10.1K |
IBBQ Hedge Fund Activity: Q3 2023 in Review
13 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q3 2023, worth a combined $7.03M — down 3.8% from $7.3M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IBBQ and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $379K. The largest seller was Tower Research Capital (TRC), cutting an estimated $301K.
- 13 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q3 2023, down from 14 in Q2 2023.
- Funds reported $7.03M of Invesco NASDAQ Biotechnology ETF stock for Q3 2023, down 3.8% quarter-over-quarter.
- 1 fund opened new Invesco NASDAQ Biotechnology ETF positions in Q3 2023 and 2 closed out, a net change of -1 holder.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q3 2023 was Citadel Advisors, an estimated $379K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q3 2023 was Tower Research Capital (TRC), an estimated $301K sold.
Based on aggregated 13F filings for Q3 2023.